Vaxart, Inc. 8-K

What Happened

• Vaxart, Inc. announced it entered a termination agreement with landlord Britannia Pointe Grand Limited Partnership on December 18, 2025 to end the lease for its headquarters at 170 Harbor Way, South San Francisco.
• The lease covers approximately 24,606 rentable square feet and will terminate effective May 15, 2026 (original lease expiration was March 31, 2029).
• The company will continue to pay rent and reimbursable expenses through the termination date; there are no termination fees and, after May 15, 2026, neither party will have remaining obligations under the lease.

Key Details

• Termination agreement signed: December 18, 2025.
• Lease termination effective date: May 15, 2026 (original expiry: March 31, 2029).
• Space affected: ~24,606 rentable sq. ft. at 170 Harbor Way, South San Francisco.
• No termination fees or penalties; Company will relocate headquarters and labs to another South San Francisco office.

Why It Matters

• This is a cash-management and cost-reduction move: terminating the lease removes a long-term rent obligation (through 2029) and consolidates operations into existing Company offices.
• Investors should note the company still must pay rent and reimbursable expenses through May 15, 2026, so near-term cash outflows remain until that date.
• The Termination Agreement will be filed as an exhibit to Vaxart’s 2025 Form 10-K; aside from the lease, there is no material relationship between the company and the landlord.